Cargando…

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial

BACKGROUND: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organization (WHO) for HIV-1-infected individuals in settings with high infectious disease prevalence. The WHO 2006 guidelines were developed prior to the scale-up of antiretroviral therapy (ART). The threshold for CTX di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polyak, Christina S., Yuhas, Krista, Singa, Benson, Khaemba, Monica, Walson, Judd, Richardson, Barbra A., John-Stewart, Grace
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701407/ https://www.ncbi.nlm.nih.gov/pubmed/26731191 http://dx.doi.org/10.1371/journal.pmed.1001934

Ejemplares similares

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis
por: Juma, Dennis W., et al.
Publicado: (2019)

Frequency and correlates of malaria over-treatment in areas of differing malaria transmission: a cross-sectional study in rural Western Kenya
por: Onchiri, Frankline M, et al.
Publicado: (2015)

Soil transmitted helminth infections are not associated with compromised antibody responses to previously administered measles and tetanus vaccines among HIV-1 infected, ART naïve Kenyan adults
por: Storey, Helen L., et al.
Publicado: (2017)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Combined effectiveness of anthelmintic chemotherapy and WASH among HIV-infected adults
por: Means, Arianna R., et al.
Publicado: (2018)

Plasma proteomic signatures of enteric permeability among hospitalized and community children in Kenya and Pakistan
por: Tickell, Kirkby D., et al.
Publicado: (2023)

Mothers’ Willingness to Use Breastfeeding Supports: Evidence From Formally Employed Mothers in Central Kenya
por: Ickes, Scott, et al.
Publicado: (2022)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*
por: Kasirye, R, et al.
Publicado: (2015)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

Impact of Helminth Diagnostic Test Performance on Estimation of Risk Factors and Outcomes in HIV-Positive Adults
por: Arndt, Michael B., et al.
Publicado: (2013)

Enteric Permeability, Systemic Inflammation, and Post-Discharge Growth Among a Cohort of Hospitalized Children in Kenya and Pakistan
por: Tickell, Kirkby D., et al.
Publicado: (2022)

Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi
por: Everett, Dean B., et al.
Publicado: (2011)

Impact of Childhood Nutritional Status on Pathogen Prevalence and Severity of Acute Diarrhea
por: Tickell, Kirkby D., et al.
Publicado: (2017)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
por: Jiang, Junjun, et al.
Publicado: (2019)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial
por: Anywaine, Zacchaeus, et al.
Publicado: (2018)

Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP
por: William, Buwembo, et al.
Publicado: (2012)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
por: Wamalwa, Dalton C, et al.
Publicado: (2010)

Infant Safety during and after Maternal Valacyclovir Therapy in Conjunction with Antiretroviral HIV-1 Prophylaxis in a Randomized Clinical Trial
por: Drake, Alison L., et al.
Publicado: (2012)

Exclusive breastfeeding among working mothers in Kenya: Perspectives from women, families and employers
por: Ickes, Scott B., et al.
Publicado: (2021)

Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial)
por: Pavlinac, Patricia B, et al.
Publicado: (2017)

Metronidazole or Cotrimoxazole Therapy Is Associated with a Decrease in Intestinal Bioavailability of Common Antiretroviral Drugs
por: Dossou-Yovo, Flore, et al.
Publicado: (2014)

Partner Disclosure and Early CD4 Response among HIV-Infected Adults Initiating Antiretroviral Treatment in Nairobi Kenya
por: Trinh, T. Tony, et al.
Publicado: (2016)

Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013)

Correlates of multi-drug non-susceptibility in enteric bacteria isolated from Kenyan children with acute diarrhea
por: Brander, Rebecca L., et al.
Publicado: (2017)

Prevalence and Correlates of Helminth Co-infection in Kenyan HIV-1 Infected Adults
por: Walson, Judd L., et al.
Publicado: (2010)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon
por: Janssen, Saskia, et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis Associated With Reduced Anemia Hazard in HIV-Exposed Infants in a Malaria-Endemic Setting
por: Ewing, Alexander, et al.
Publicado: (2017)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study
por: Silverman, Rachel A., et al.
Publicado: (2019)

Successful treatment of cerebral toxoplasmosis with cotrimoxazole
por: Patil, Harsha V., et al.
Publicado: (2011)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

Treatment of Helminth Co-Infection in Individuals with HIV-1: A Systematic Review of the Literature
por: Walson, Judd L., et al.
Publicado: (2007)

Plasmid-mediated quinolone resistance genes detected in Ciprofloxacin non-susceptible Escherichia coli and Klebsiella isolated from children under five years at hospital discharge, Kenya
por: Kariuki, Kevin, et al.
Publicado: (2023)

Facilitators and barriers to cotrimoxazole and nevirapine prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, E, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lkr7u5qft62jt39b1p9b43bg14